These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21453465)

  • 41. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.
    Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM
    Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
    Phan GT; de Vries PJ; Tran BQ; Le HQ; Nguyen NV; Nguyen TV; Heisterkamp SH; Kager PA
    Trop Med Int Health; 2002 Oct; 7(10):858-64. PubMed ID: 12358621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.
    Thanh PV; Hong NV; Van NV; Louisa M; Baird K; Xa NX; Peeters Grietens K; Hung le X; Duong TT; Rosanas-Urgell A; Speybroeck N; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7411-9. PubMed ID: 26392501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic efficacy of Chloroquine for the treatment of uncomplicated Plasmodium vivax infection in Shewa Robit, Northeast Ethiopia.
    Belay H; Alemu M; Hailu T; Mohammed H; Sime H; Hailegeorgies H; Gidey B; Haile M; Assefa G; Bekele W; Alebachew Reta M; Almaw Tamene A; Tasew G; Assefa A
    PLoS One; 2023; 18(1):e0277362. PubMed ID: 36634046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
    Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon.
    Siqueira AM; Coutinho LI; Gurgel RL; Su WC; Carvalho LM; Benzecry SG; Alencar AC; Alexandre MA; Alecrim MG; Lacerda MV
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):540-5. PubMed ID: 25099334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
    Phyo AP; Lwin KM; Price RN; Ashley EA; Russell B; Sriprawat K; Lindegardh N; Singhasivanon P; White NJ; Nosten F
    Clin Infect Dis; 2011 Nov; 53(10):977-84. PubMed ID: 22002979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chloroquine-resistant Plasmodium vivax malaria in Peru.
    Ruebush TK; Zegarra J; Cairo J; Andersen EM; Green M; Pillai DR; Marquiño W; Huilca M; Arévalo E; Garcia C; Solary L; Kain KC
    Am J Trop Med Hyg; 2003 Nov; 69(5):548-52. PubMed ID: 14695094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
    Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
    Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmodium vivax clinically resistant to chloroquine in Colombia.
    Soto J; Toledo J; Gutierrez P; Luzz M; Llinas N; Cedeño N; Dunne M; Berman J
    Am J Trop Med Hyg; 2001 Aug; 65(2):90-3. PubMed ID: 11508397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.
    Höglund R; Moussavi Y; Ruengweerayut R; Cheomung A; Äbelö A; Na-Bangchang K
    Malar J; 2016 Feb; 15():129. PubMed ID: 26928448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia.
    Yohannes AM; Teklehaimanot A; Bergqvist Y; Ringwald P
    Am J Trop Med Hyg; 2011 Jan; 84(1):137-40. PubMed ID: 21212216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of pyronaridine-artesunate (Pyramax
    Mohammed H; Sime H; Hailgiorgis H; Chernet M; Alebachew M; Solomon H; Assefa G; Haile M; Girma S; Bekele W; Tasew G; Gidey B; Commons RJ; Assefa A
    Malar J; 2022 Dec; 21(1):401. PubMed ID: 36587210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin.
    de Sena LWP; Mello AGNC; Ferreira MVD; de Ataide MA; Dias RM; Vieira JLF
    Malar J; 2019 Dec; 18(1):439. PubMed ID: 31864358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal Plasmodium vivax malaria.
    Oróstegui-Pinilla D; Rodríguez-Morales AJ
    Trop Biomed; 2011 Aug; 28(2):339-42. PubMed ID: 22041754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.